Hiwasa T, Fujita-Yoshigaki J, Shirouzu M, Koide H, Sawada T, Sakiyama S, Yokoyama S
Division of Biochemistry, Chiba Cancer Center Research Institute, Japan.
Cancer Lett. 1993 May 14;69(3):161-5. doi: 10.1016/0304-3835(93)90169-a.
Protease-inhibitory activity of recombinant Ha-ras gene products (Ras) toward papain and cathepsins B and L was investigated. v-Ha-Ras showed more potent inhibitory activity toward cathepsin B as compared with c-Ha-Ras. We have also investigated protease-inhibitory activity of c-Ha-Ras mutants with point mutations in amino acids between positions 23 and 50. Inhibitory activity of Ras toward papain and cathepsin L was not largely altered among mutants. However, the inhibitory activity toward cathepsin B was significantly impaired by a mutation at position 43, 44, 45 or 48. These results suggest that 43Gln-Val-Val sequence plays an important role at least to inhibit cathepsin B.
研究了重组Ha-ras基因产物(Ras)对木瓜蛋白酶、组织蛋白酶B和L的蛋白酶抑制活性。与c-Ha-Ras相比,v-Ha-Ras对组织蛋白酶B表现出更强的抑制活性。我们还研究了在23至50位氨基酸之间存在点突变的c-Ha-Ras突变体的蛋白酶抑制活性。Ras对木瓜蛋白酶和组织蛋白酶L的抑制活性在突变体之间没有很大变化。然而,在43、44、45或48位的突变显著损害了对组织蛋白酶B的抑制活性。这些结果表明,43Gln-Val-Val序列至少在抑制组织蛋白酶B方面起着重要作用。